Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Groark JG"'
Autor:
Sheikh SZ; University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA., Englund TR; University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA., Burriss SW; GlaxoSmithKline, Collegeville, Pennsylvania, USA., Bull J; Strategic Regulatory Consultants, Washington, DC, USA., Harry A; GlaxoSmithKline, Collegeville, Pennsylvania, USA., Groark JG; GlaxoSmithKline, Collegeville, Pennsylvania, USA., Hall AM; GlaxoSmithKline, Collegeville, Pennsylvania, USA., Miller M; GlaxoSmithKline, Collegeville, Pennsylvania, USA., Roth DA; GlaxoSmithKline, Collegeville, Pennsylvania, USA.
Publikováno v:
ACR open rheumatology [ACR Open Rheumatol] 2022 Sep; Vol. 4 (9), pp. 747-752. Date of Electronic Publication: 2022 Jun 24.
Autor:
Ginzler E; State University of New York (SUNY) Downstate Health Sciences University, New York., Guedes Barbosa LS; Núcleo de Terapia Especializada em Cancerologia (NUTEC), Cuiaba, Brazil., D'Cruz D; Guy's Hospital, London, UK., Furie R; Northwell Health, Great Neck, New York., Maksimowicz-McKinnon K; Henry Ford Health System, Detroit, Michigan., Oates J; Medical University of South Carolina and Ralph H. Johnson VA Medical Center, Charleston, South Carolina., Santiago MB; Escola Bahiana de Medicina e Saúde Pública, Salvador, Bahia, Brazil., Saxena A; NYU Grossman School of Medicine, New York., Sheikh S; University of North Carolina, Chapel Hill., Bass DL; GlaxoSmithKline, Collegeville, Pennsylvania., Burriss SW; GlaxoSmithKline, Collegeville, Pennsylvania., Gilbride JA; GlaxoSmithKline, Stevenage, UK., Groark JG; GlaxoSmithKline, Collegeville, Pennsylvania., Miller M; GlaxoSmithKline, Collegeville, Pennsylvania., Pierce A; ViiV Healthcare, Research Triangle, North Carolina., Roth DA; GlaxoSmithKline, Collegeville, Pennsylvania., Ji B; GlaxoSmithKline, Uxbridge, UK.
Publikováno v:
Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2022 Jan; Vol. 74 (1), pp. 112-123. Date of Electronic Publication: 2021 Dec 09.
Autor:
van Vollenhoven RF; Department of Rheumatology, Amsterdam Rheumatology and Immunology Center ARC, Amsterdam, The Netherlands., Stohl W; University of Southern California Keck School of Medicine, Los Angeles, California, USA., Furie RA; Northwell Health, Great Neck, New York, USA., Fox NL; GSK, Clinical Development - Immuno-Inflammation, Rockville, Maryland, USA (at the time of the study)., Groark JG; GSK, Clinical Development - Immuno-Inflammation, Philadelphia, Pennsylvania, USA., Bass D; GSK, Immuno-Inflammation and Future Pipeline, Collegeville, Pennsylvania, USA., Kurtinecz M; GSK, Biostatistics, Immuno-Inflammation, Collegeville, Pennsylvania, USA., Pobiner BF; GSK, Medical Affairs, Research Triangle Park, North Carolina, USA., Eastman WJ; GSK, Medical Affairs - Immuno-Inflammation, Research Triangle Park, North Carolina, USA (at the time of the study)., Gonzalez-Rivera T; GSK, Medical Affairs, Rockville, Maryland, USA., Gordon D; GSK, Clinical Development - Immuno-Inflammation, Rockville, Maryland, USA (at the time of the study).
Publikováno v:
Lupus science & medicine [Lupus Sci Med] 2018 Nov 26; Vol. 5 (1), pp. e000288. Date of Electronic Publication: 2018 Nov 26 (Print Publication: 2018).
Autor:
Furie, Richard, Morand, Eric F., Bruce, Ian N., Isenberg, David, van Vollenhoven, Ronald, Abreu, Gabriel, Pineda, Lilia, Tummala, Raj
Publikováno v:
Arthritis & Rheumatology; Nov2021, Vol. 73 Issue 11, p2059-2068, 10p